Back to search
Primary Lateral Sclerosis, Adult, 1
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Lateral Sclerosis, Adult, 1 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Lateral Sclerosis, Adult, 1 trials you may qualify forThis study is a placebo-controlled Phase I study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the antisense oligonucleotide (…
The purpose of this study is to investigate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of TCD601 (siplizumab) in newly diagnosed adult ALS pat…
Researchers will evaluate the safety, tolerability, and pharmacokinetics (PK) of orally administered Amisodin in healthy adult subjects through a randomized, do…
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics and pharmacodynamics of oral doses of FB418 in healthy adult subjects and…
This is the study of AMT-162 in Participants with SOD1-ALS and is designed to evaluate the safety, tolerability, and exploratory efficacy of intrathecally admin…
This Individual Patient Expanded Access IND has been created as requested by an 83-year-old man who suffers Primary Lateral Sclerosis and for which the drugs cu…
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.